« Back to Record
Citation APA

Le Calve, B., Cros, J., de la Fouchardiere, C., Dubus, P., Guitton, J., Bartholin, L., Bachet, J.-B., Bernard, D., Griveau, A., Vindrieux, D., Marechal, R., Wiel, C., Svrcek, M., Gout, J., Azzi, L., & Payen, L. (2016). Lysyl oxidase family activity promotes resistance of pancreatic ductal adenocarcinoma to chemotherapy by limiting the intratumoral anticancer drug distribution. Oncotarget, 7(22), 32100-32112. doi:10.18632/oncotarget.8527


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/236911

Le Calve, B., Cros, J., de la Fouchardiere, C., Dubus, P., Guitton, J., Bartholin, L., Bachet, J.-B., Bernard, D., Griveau, A., Vindrieux, D., Marechal, R., Wiel, C., Svrcek, M., Gout, J., Azzi, L., & Payen, L. (2016). Lysyl oxidase family activity promotes resistance of pancreatic ductal adenocarcinoma to chemotherapy by limiting the intratumoral anticancer drug distribution. Oncotarget, 7(22), 32100-32112. doi:10.18632/oncotarget.8527